Vaxxinity, Inc. (VAXX) Income Annual - Discounting Cash Flows
VAXX
Vaxxinity, Inc.
VAXX (OTC)
Period Ending: LTM
(Last Twelve Months)
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
Report Filing 2024-03-27 2024-03-27 2023-03-27 2022-03-24 2020-12-31 2019-12-31
Revenue 0 0 0 0.066 0.557 0
Cost of Revenue 1.63 2.23 1.68 1.94 0.052 0.107
Gross Profit -1.63 -2.23 -1.68 -1.87 0.505 -0.107
Operating Expenses 56.7 56.05 74.3 123.2 32.79 13.55
Research & Development 35.44 33.66 47.63 71.38 20.57 10.66
Selling, General and Administrative 22.43 22.39 28.35 51.83 12.22 3
Other Operating Expenses -1.18 0 -1.68 0 0 -0.107
Operating Income -58.33 -58.28 -75.98 -125.1 -32.28 -13.66
Net Non-Operating Interest 1.39 1.39 0.745 -0.831 -1.18 0
Interest Income 2.09 2.09 1.26 0.009 0 0.435
Interest Expense 0.696 0.696 0.514 0.84 1.18 0.435
Equity & Other Income/(Expense) 0.001 56.83 0.012 -11.27 -6.49 -0.502
Income Before Tax -56.94 -0.057 -75.22 -137.2 -39.96 -14.16
Income Tax Expense 0 0 -0.012 0 0 0.056
Income Attributable to Non-Controlling Interest 0 0 0 0 0 0
Net Income -56.94 -0.057 -75.21 -137.2 -39.96 -14.22
Depreciation and Amortization 2.22 2.23 1.68 1.1 0.717 0.107
EBITDA -56.11 -56.05 -74.3 -124 -31.57 -13.55
Earnings Per Share (EPS) -0.45 -0.001 -0.6 -1.09 -0.32 -0.11
Diluted Earnings Per Share -0.45 -0.001 -0.6 -1.09 -0.32 -0.11
Weighted Average Shares Outstanding 127.2 126.5 125.9 125.4 125.5 125.5
Diluted Weighted Average Shares Outstanding 127.2 126.5 125.9 125.4 125.5 125.5
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program